Candel Therapeutics
Price & Volume
Stats
See more52W Range | $0.77-$14.30 |
Market Cap | $129.2M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $31,000 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$20.6M |
Diluted EPS | -$1.73 |
News
See moreYahoo Finance • 12 months ago
Candel Therapeutics Announces Restructuring to Prioritize Resources on Key Value Drivers for Expanded Development of CAN-3110, the enLIGHTEN™ Discovery Platform, and Key Clinical Readouts for CAN-2409
Yahoo Finance • last year
Candel Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights
Yahoo Finance • last year
Candel Therapeutics Presents Preclinical Data from its enLIGHTEN™ Discovery Platform at SITC
About
CEO | Dr. Paul-Peter Tak FOCIS, M.D., Ph.D. |
CFO | Mr. Charles Schoch |
Address | 117 Kendrick Street, Needham, MA, United States, 02494 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 42 |
